A North East biotech business is set to bring a ground-breaking cell preservation product to market after raising more than £425,000 in investment.
Newcastle University spin-out Atelerix was launched in 2017 by co-founders Professor Che Connon, Dr Steve Swioklo and Dr Mick McLean.
The company aims to revolutionise cell preservation by changing the way cells and tissues are stored and transported. It has raised £425,574 in investment to help fully commercialise its product and bring it to market.